Breaking news – Pagina 403

Marzo 1, 2015 Riccardo Raneri

FDA Drug Safety Communication: FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients

25/02/2015 http://www.fda.gov/Drugs/DrugSafety/ucm435271.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery

Leggi

Marzo 1, 2015 Riccardo Raneri

The Committee for Medicinal Products for Human Use (CHMP) recommended the addition of a new formulation to the marketing authorisation of Optisulin (insulin glargine) and a change of its invented name to Toujeo.

The new formulation of Toujeo is a higher-strength insulin (300 units/ml) 26/02/2015 http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000309/smops/Positive/human_smop_000789.jsp&mid=WC0b01ac058001d127

Leggi

Gennaio 8, 2017 Riccardo Raneri

The Diabetic HFpEF Phenotype: Is it Real and is it Worth Targeting Therapeutically?

Lindman BR
Circulation. Pub. online January 4, 2017

Leggi

Gennaio 8, 2017 Riccardo Raneri

Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients with Heart Failure and Preserved Ejection Fraction. A Report from the Irbesartan in Heart Failure with Preserved Ejection Fraction Trial (I-

Kristensen SL, Mogensen UM, Jhund PS, et al.
Circulation. Pub. online January 4, 2017

Leggi

Gennaio 11, 2017 Riccardo Raneri

An Evidence-Based Medicine Approach to Antihyperglycemic Therapy in Diabetes Mellitus to Overcome Overtreatment

Makam AN and Nguyen OK
Circulation 2017;135:180-95

Leggi

Gennaio 9, 2017 Riccardo Raneri

Strategies Used by Patients with Type 1 Diabetes to Avoid Hypoglycemia in a 24×1-Hour Marathon: Comparison with the Amounts of Carbohydrates Estimated by a Customizable Algorithm

Alex Buoite Stella, Roberta Assaloni, Laura Tonutti, Elena Manca, Carla Tortul, Riccardo Candido, Maria Pia Francescato
Canadian Journal of Diabetes 2016. Articles in Press

Leggi

Gennaio 10, 2017 Riccardo Raneri